Real-World Data of Tigecycline-Associated Drug-Induced Liver Injury Among Patients in China: A 3-year Retrospective Study as Assessed by the Updated RUCAM

Background: Tigecycline, a glycylcycline antibiotic, is increasingly used clinically for the treatment of severe infections caused by multidrug-resistant bacteria, but it is also associated with hepatotoxicity. However, the incidence and risk factors of tigecycline-associated drug-induced liver inju...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Xiaoping, Zuo, Chengchun, Yu, Lingling, Lao, Donghui, Li, Xiaoyu, Xu, Qing, Lv, Qianzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594628/
https://www.ncbi.nlm.nih.gov/pubmed/34795591
http://dx.doi.org/10.3389/fphar.2021.761167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594628/
https://www.ncbi.nlm.nih.gov/pubmed/34795591
http://dx.doi.org/10.3389/fphar.2021.761167

Ejemplares similares